KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Leases: 2009-2011

Historic Current Leases for Acadia Pharmaceuticals (ACAD) over the last 3 years, with Dec 2011 value amounting to $32,000.

  • Acadia Pharmaceuticals' Current Leases was N/A to $3,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $3,000, marking a year-over-year change of. This contributed to the annual value of $32,000 for FY2011, which is negligibly% changed negligibly from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Current Leases of $32,000 as of FY2011, which was down 0.00% from $32,000 recorded in FY2010.
  • Acadia Pharmaceuticals' Current Leases' 5-year high stood at $98,000 during FY2009, with a 5-year trough of $32,000 in FY2010.
  • In the last 3 years, Acadia Pharmaceuticals' Current Leases had a median value of $32,000 in 2011 and averaged $54,000.
  • Data for Acadia Pharmaceuticals' Current Leases shows a maximum YoY slumped of 67.35% (in 2010) over the last 5 years.
  • Acadia Pharmaceuticals' Current Leases (Yearly) stood at $98,000 in 2009, then plummeted by 67.35% to $32,000 in 2010, then remained steady at $32,000 in 2011.